Nuvalent Inc (NUVL)
70.95
-1.69
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
70.95
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Shareholders Equity (Quarterly): 675.04M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 675.04M |
| December 31, 2023 | 700.56M |
| September 30, 2023 | 395.98M |
| June 30, 2023 | 421.15M |
| March 31, 2023 | 443.97M |
| December 31, 2022 | 462.98M |
| September 30, 2022 | 236.58M |
| Date | Value |
|---|---|
| June 30, 2022 | 252.98M |
| March 31, 2022 | 268.92M |
| December 31, 2021 | 285.04M |
| September 30, 2021 | 301.13M |
| June 30, 2021 | -47.74M |
| March 31, 2021 | 12.14M |
| December 31, 2020 | -31.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.74M
Minimum
Jun 2021
700.56M
Maximum
Dec 2023
312.67M
Average
293.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Geron Corp | 344.87M |
| Verastem Inc | 46.22M |
| Karyopharm Therapeutics Inc | -168.96M |
| Syndax Pharmaceuticals Inc | 491.89M |
| AnaptysBio Inc | 47.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 708.47M |
| Total Liabilities (Quarterly) | 33.43M |